<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="ko" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJM</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Medicine</journal-title><abbrev-journal-title>Korean J Med</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">1738-9364</issn>
<issn pub-type="epub">2289-0769</issn>
<publisher>
<publisher-name>The Korean Journal of Medicine</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3904/kjm.2024.99.1.50</article-id>
<article-id pub-id-type="publisher-id">kjm-99-1-50</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
<subj-group subj-group-type="heading">
<subject>Infectious disease</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>만성 폐쇄성 폐질환으로 저용량 스테로이드 유지 중인 환자에게 발생한 <italic>Nocardia abscessus</italic>에 의한 다발성 근육 농양 1예</article-title>
<trans-title-group>
<trans-title xml:lang="en">Multiple Intramuscular Abscesses Caused by <italic>Nocardia abscessus</italic> in a Patient with Chronic Obstructive Lung Disease: Clinical Microbiology Considerations</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>Jung-Ah</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>김</surname><given-names>정아</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjm-99-1-50"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Dong</surname><given-names>Hyunjoo</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>동</surname><given-names>현주</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjm-99-1-50"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Eunjung</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>이</surname><given-names>은정</given-names></name>
</name-alternatives>
<xref ref-type="corresp" rid="c1-kjm-99-1-50"/>
<xref ref-type="aff" rid="af2-kjm-99-1-50"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Jung</surname><given-names>Jongtak</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>정</surname><given-names>종탁</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af2-kjm-99-1-50"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Baek</surname><given-names>Yae Jee</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>백</surname><given-names>예지</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af2-kjm-99-1-50"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>Tae Hyong</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>김</surname><given-names>태형</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af2-kjm-99-1-50"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Choi</surname><given-names>Tae Youn</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>최</surname><given-names>태윤</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjm-99-1-50"><sup>1</sup></xref>
</contrib>
<aff-alternatives id="af1-kjm-99-1-50">
<aff xml:lang="en"><label>1</label>Department of Laboratory Medicine, Soonchunhyang University Hospital Seoul, Seoul, <country>Korea</country></aff>
<aff xml:lang="ko"><label>1</label>순천향대학교 서울병원 진단검사의학과</aff>
</aff-alternatives>
<aff-alternatives id="af2-kjm-99-1-50">
<aff xml:lang="en"><label>2</label>Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Hospital Seoul, Seoul, <country>Korea</country></aff>
<aff xml:lang="ko"><label>2</label>순천향대학교 서울병원 감염내과</aff>
</aff-alternatives>
</contrib-group>
<author-notes><corresp id="c1-kjm-99-1-50" xml:lang="en">Correspondence to Eunjung Lee, M.D., Ph.D. Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Hospital Seoul, 59 Daesagwan-ro, Yongsan-gu, Seoul 04401, Korea Tel: +82-2-709-9034, Fax: +82-2-709-9083, E-mail: <email>shegets@schmc.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>2</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>2</month>
<year>2024</year></pub-date>
<volume>99</volume>
<issue>1</issue>
<fpage>50</fpage>
<lpage>56</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>7</month>
<year>2023</year></date>
<date date-type="rev-recd">
<day>9</day>
<month>10</month>
<year>2023</year></date>
<date date-type="accepted">
<day>10</day>
<month>10</month>
<year>2023</year></date>
</history>
<permissions>
<copyright-statement xml:lang="en">Copyright &#x000A9; 2024 The Korean Association of Internal Medicine</copyright-statement>
<copyright-year>2024</copyright-year>
<license xml:lang="en">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<trans-abstract xml:lang="en"><p>Nocardiosis is uncommon. Immunocompromising conditions predispose individuals to pulmonary and disseminated nocardiosis of the brain, skin, and subcutaneous tissues. The most common pathogens are <italic>Nocardia cyriacigeorgica</italic>, <italic>Nocardia nova</italic>, and <italic>Nocardia farcinica</italic>. The speciation of <italic>Nocardia</italic> to determine antimicrobial susceptibility is difficult using traditional biochemical methods. Here, we report the case of a 73-year-old man with chronic obstructive lung disease who developed a rapidly progressing intramuscular abscess around the left hip and thigh. Within 3 days, the lesions progressed to an epidural abscess at the L4 to S1 level. Although he was treated with broad-spectrum antibiotics and extensive incision and drainage, he died of rapidly progressive respiratory failure. <italic>Nocardia abscessus</italic> (<italic>N. abscessus</italic>) was identified in pus samples using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). This case shows that the diagnosis of an intramuscular abscess caused by <italic>N. abscessus</italic> is challenging and that using MALDI-TOF MS may facilitate the diagnosis and ensure appropriate treatment.</p></trans-abstract>
<kwd-group xml:lang="ko">
<kwd><italic>Nocardia abscessus</italic></kwd>
<kwd>근육 내 농양</kwd>
<kwd>면역저하자</kwd>
<kwd>MALDI-MS</kwd>
</kwd-group>
<kwd-group xml:lang="en">
<kwd><italic>Nocardia abscessus</italic></kwd>
<kwd>Intramuscular abscess</kwd>
<kwd>Immunocompromised host</kwd>
<kwd>MALDI-MS</kwd>
</kwd-group></article-meta></front>
<body>
<sec>
<title>INTRODUCTION</title>
<p>Nocardia species are aerobic, Gram-positive, beaded, weakly acid-fast, branching rods. Nocardiosis results from infection by members of the genus Nocardia, which are ubiquitous environmental saprophytes that cause localized or disseminated diseases in humans via inhalation or inoculation &#x005B;<xref ref-type="bibr" rid="b1-kjm-99-1-50">1</xref>&#x005D;. Immunocompromised individuals with deficient cell-mediated immunity, especially that associated with lymphoma, transplantation, glucocorticoid therapy, or human immunodeficiency virus infection, are at risk for Nocardiosis &#x005B;<xref ref-type="bibr" rid="b2-kjm-99-1-50">2</xref>&#x005D;. Pneumonia is the most common form of Nocardia disease, and other common sites include the brain, skin and soft tissues, kidneys, joints, bones, and eyes &#x005B;<xref ref-type="bibr" rid="b1-kjm-99-1-50">1</xref>-<xref ref-type="bibr" rid="b3-kjm-99-1-50">3</xref>&#x005D;. Muscle involvement is rare and a typical manifestation of muscle infection is a subacute intramuscular abscess &#x005B;<xref ref-type="bibr" rid="b4-kjm-99-1-50">4</xref>&#x005D;. Here, we present a rare case of rapidly progressive multifocal intramuscular abscesses caused by <italic>Nocardia abscessus</italic> identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).</p>
</sec>
<sec>
<title>CASE REPORT</title>
<p>A 73-year-old man presented to the emergency department with progressive back pain and pain radiating down the left leg that had worsened over the past 25 days. He also reported fever and chills. His medical history included chronic obstructive lung disease (COPD) treated with home O<sub>2</sub> therapy, prednisolone 5 mg/day, and montelukast sodium 10 mg/day. He had received an epidural nerve block 3 days previously.</p>
<p>On admission, he had a temperature of 38.7&#x02103;, heart rate of 120 beats/min, and blood pressure of 87/56 mmHg. His oxygen saturation was 88% while breathing ambient air. Physical examination revealed decreased sounds in both lungs and severe tenderness of the buttocks and left thigh. The motor and sensory functions of both legs were intact. Laboratory tests revealed a white blood cell count of 45.7/&#x000b5;L, hemoglobin of 12.1 g/dL, platelet count of 407.0 &#x000d7; 103/&#x003bc;L, C-reactive protein level of 22.5 mg/dL (normal range, 0-0.5), procalcitonin level of 8.9 ng/mL, and lactic acid level of 3.0 mmol/L. Three sets of blood cultures on blood agar and MacConkey agar plates for 5 days were negative.</p>
<p>On the first day of admission, chest radiography and chest and abdominopelvic computed tomography (CT) showed extensive emphysema with chronic bronchitis, and revealed extensive intramuscular abscesses involving the left psoas, iliacus, spinalis thoracis, longissimus thoracis, gluteus maximus, and piriformis muscles (<xref rid="f1-kjm-99-1-50" ref-type="fig">Fig. 1A, B</xref>). On the fourth day after admission, the pain in the left hip and thigh worsened despite the administration of broad-spectrum antibiotics (levofloxacin and vancomycin) and analgesics. Lumbar spine CT revealed a combined anterior epidural abscess at the L4 to S1 levels and suggested bony involvement of the left sacrum and lower lumbar spine. On the sixth day after admission, incision and pus drainage of the left iliopsoas, gluteal, and paravertebral abscesses were done to relieve pain and as definitive treatment. Yellow and brown pus was released from the psoas, iliacus, and paraspinal muscles (<xref rid="f1-kjm-99-1-50" ref-type="fig">Fig. 1C, D</xref>). The psoas and paraspinal muscle histopathology showed many acute inflammatory cells with macrophages in a necrotic background. Gram stain and culture of pus and tissue specimens from the psoas, iliacus, and paraspinal muscles and Gram staining of surgical specimens initially showed no bacteria, but after 2 days incubation, Gram-positive filamentous rods were observed on Gram staining of cultured colonies. Four hours after the colonies were grown, the bacteria were identified as <italic>Nocardia abscessus</italic> using MALDI-TOF MS (<xref rid="f2-kjm-99-1-50" ref-type="fig">Fig. 2</xref>). On the eighth day after admission, the acute exacerbation of COPD continued to progress, despite mechanical ventilation and the administration of high-dose steroids, and the patient died.</p>
</sec>
<sec>
<title>DISCUSSION</title>
<p>The organs most frequently infected by Nocardia are the respiratory tract, brain, and skin/soft tissues &#x005B;<xref ref-type="bibr" rid="b1-kjm-99-1-50">1</xref>-<xref ref-type="bibr" rid="b3-kjm-99-1-50">3</xref>&#x005D;. Intramuscular nocardiosis is rare; to our knowledge, only 15 cases have been reported (<xref rid="t1-kjm-99-1-50" ref-type="table">Table 1</xref>), including six cases each of <italic>Nocardia asteroids (N. asteroids)</italic> and <italic>Nocardia farcinica</italic> &#x005B;<xref ref-type="bibr" rid="b5-kjm-99-1-50">5</xref>-<xref ref-type="bibr" rid="b8-kjm-99-1-50">8</xref>&#x005D;. The psoas is the most common site of intramuscular infection due to its rich vascular nature, and a secondary psoas abscess may occur as local spread from the viscera along the iliopsoas. In an analysis of 93 psoas abscesses for which the causative microorganisms were identified over 15 years &#x005B;<xref ref-type="bibr" rid="b9-kjm-99-1-50">9</xref>&#x005D;, there was one case of <italic>Nocardia</italic> (<italic>N. asteroides</italic>). In a literature review (<xref rid="t1-kjm-99-1-50" ref-type="table">Table 1</xref>), in 6/15 (40%) of cases, the muscle was the primary site of infection; in 9/15 (60%) of cases, multiple organs such as lung, brain, bone, and spleen were co-infected. Most (13/15 cases; 87%) patients were immunocompromised and three patients (cases 3, 5, and 6), including an immunocompetent patient, had jobs with a risk of <italic>Nocardia</italic> inhalation or inoculation. In our case, although 5 mg/day prednisolone is not an immunosuppressive dose, inhalation might have been a route of Nocardia infection, considering the patient&#x02019;s very severe COPD with home O2 therapy and bed-ridden state.The organs most frequently infected by Nocardia are the respiratory tract, brain, and skin/soft tissues &#x005B;<xref ref-type="bibr" rid="b1-kjm-99-1-50">1</xref>-<xref ref-type="bibr" rid="b3-kjm-99-1-50">3</xref>&#x005D;. Intramuscular nocardiosis is rare; to our knowledge, only 15 cases have been reported (<xref rid="t1-kjm-99-1-50" ref-type="table">Table 1</xref>), including six cases each of <italic>Nocardia asteroids (N. asteroids)</italic> and Nocardia farcinica &#x005B;<xref ref-type="bibr" rid="b5-kjm-99-1-50">5</xref>-<xref ref-type="bibr" rid="b8-kjm-99-1-50">8</xref>&#x005D;. The psoas is the most common site of intramuscular infection due to its rich vascular nature, and a secondary psoas abscess may occur as local spread from the viscera along the iliopsoas. In an analysis of 93 psoas abscesses for which the causative microorganisms were identified over 15 years &#x005B;<xref ref-type="bibr" rid="b9-kjm-99-1-50">9</xref>&#x005D;, there was one case of Nocardia (N. asteroides). In a literature review (<xref rid="t1-kjm-99-1-50" ref-type="table">Table 1</xref>), in 6/15 (40%) of cases, the muscle was the primary site of infection; in 9/15 (60%) of cases, multiple organs such as lung, brain, bone, and spleen were co-infected. Most (13/15 cases; 87%) patients were immunocompromised and three patients (cases 3, 5, and 6), including an immunocompetent patient, had jobs with a risk of Nocardia inhalation or inoculation. In our case, although 5 mg/day prednisolone is not an immunosuppressive dose, inhalation might have been a route of Nocardia infection, considering the patient&#x02019;s very severe COPD with home O2 therapy and bed-ridden state.</p>
<p>As empirical antibiotics for typical intramuscular abscesses are not effective for abscesses caused by <italic>Nocardia</italic> species, identification and antibiotic susceptibility tests followed by culture should not be delayed. Since <italic>Nocardia</italic> has a low blood culture detection rate of 38% and a median incubation time of 4 days &#x005B;<xref ref-type="bibr" rid="b10-kjm-99-1-50">10</xref>&#x005D;, incision and drainage should be performed to obtain samples as soon as possible. As intramuscular abscesses are usually subacute, there was usually sufficient time to identify the <italic>Nocardia</italic> species and prescribe specific antibiotics in most of the reported cases (<xref rid="t1-kjm-99-1-50" ref-type="table">Table 1</xref>). However, our patient had an acute manifestation of Nocardiosis and died before the final culture results were available. Although only 2 days were taken to identify the <italic>Nocardia abscessus</italic> (<italic>N. abscessus</italic>), incision and drainage were delayed due to the patient&#x02019;s unstable general condition and were performed after the sixth day of hospitalization. Empirical antibiotics for intramuscular abscesses, such as levofloxacin and vancomycin, ultimately proved ineffective. Case 1 in the literature review (<xref rid="t1-kjm-99-1-50" ref-type="table">Table 1</xref>), was lost to follow-up after using penicillin without microbial identification and died 3 months later due to dissemination. We suspected <italic>Nocardia</italic> in that case because filamentous shapes were observed on Gram staining. The differential diagnosis of Gram-positive rods includes <italic>Corynebacterium, Listeria, Lactobacillus, Actinomyces</italic> (mainly as bacterial contaminants), and <italic>Nocardia</italic> species. If the Gram-positive rods are filamentous, <italic>Nocardia</italic> should be considered. Moreover, if staining for acid-fast bacilli reveals specific aerial hyphae, it helps to confirm <italic>Nocardia</italic> &#x005B;<xref ref-type="bibr" rid="b1-kjm-99-1-50">1</xref>&#x005D;. If cultured, Nocardia can be identified accurately using MALDI-TOF MS or 16S rRNA sequencing &#x005B;<xref ref-type="bibr" rid="b1-kjm-99-1-50">1</xref>-<xref ref-type="bibr" rid="b3-kjm-99-1-50">3</xref>&#x005D;. MALDI-TOF MS is used more commonly, owing to its short time and ease of use compared with 16S rRNA sequencing. The concordance between MALDI-TOF MS and 16S rRNA sequencing at the species/complex level is 97.3% &#x005B;<xref ref-type="bibr" rid="b3-kjm-99-1-50">3</xref>&#x005D;.</p>
<p>The 2019 updated guidelines for <italic>Nocardia</italic> infection &#x005B;<xref ref-type="bibr" rid="b10-kjm-99-1-50">10</xref>&#x005D; recommended that the initial selection of an antimicrobial regimen be based on the <italic>Nocardia</italic> species. <italic>N. abscessus</italic> is generally susceptible to trimethoprim/sulfamethoxazole (TMP/SMX), amikacin, ceftriaxone, amoxicillin-clavulanic acid, tigecycline, variably susceptible to imipenem and minocycline, and resistant to ciprofloxacin, moxifloxacin, and clarithromycin/azithromycin. However, in an analysis over 10 years conducted in Spain &#x005B;<xref ref-type="bibr" rid="b2-kjm-99-1-50">2</xref>&#x005D;, 2.8% and 4.2% of <italic>N. abscessus</italic> isolates were resistant to TMP/SMX and amoxicillin-clavulanic acid, respectively.</p>
<p>In summary, this case of multifocal intramuscular abscess caused by <italic>N. abscessus</italic> has educational value. Although the incidence of nocardiosis is increasing globally &#x005B;<xref ref-type="bibr" rid="b10-kjm-99-1-50">10</xref>&#x005D;, intramuscular abscesses are still uncommon. This case highlights the importance of considering the possibility of <italic>Nocardia</italic> in patients with muscle abscesses and the value of using molecular techniques for identifying <italic>Nocardia</italic>.</p></sec></body>
<back>
<fn-group>
<fn fn-type="conflict"><p><bold>CONFLICTS OF INTEREST</bold></p><p>No potential conflicts of interest relevant to this article was reported.</p></fn>
<fn fn-type="financial-disclosure"><p><bold>FUNDING</bold></p><p>This research was supported by the Soonchunhyang University Research Fund.</p></fn>
<fn fn-type="participating-researchers"><p><bold>AUTHOR CONTRIBUTIONS</bold></p>
<p>Conceptualization: Jung-ah Kim, Eunjung Lee, Tae Hyong Kim, Jongtak Jung, and Yae Jee Baek.</p>
<p>Data curation: Jung-ah Kim and Eunjung Lee.</p>
<p>Formal analysis: Jung-ah Kim.</p>
<p>Methodology: Hyunjoo Dong and Tae Youn Choi.</p>
<p>Writing - original draft: Jung-ah Kim and Eunjung Lee.</p>
<p>Writing - review &amp; editing: Tae Youn Choi, Tae Hyong Kim, Eunjung Lee, Jongtak Jung, and Yae Jee Baek.</p>
</fn>
</fn-group>
<ack><p>The authors thank the orthopedic surgeon, Sung-Woo Choi who performed incision and drainage despite the patient’s critical condition, and the respiratory physician, Youngeun Jang who provided respiratory care to the patient after surgery.</p></ack>
<ref-list xml:lang="en">
<title>REFERENCES</title>
<ref id="b1-kjm-99-1-50">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Galar</surname><given-names>A</given-names></name>
<name><surname>Mart&#x000ed;n-Rabad&#x000e1;n</surname><given-names>P</given-names></name>
<name><surname>Mar&#x000ed;n</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Revisiting nocardiosis at a tertiary care institution: any change in recent years?</article-title>
<source>Int J Infect Dis</source>
<year>2021</year>
<volume>102</volume>
<fpage>446</fpage>
<lpage>454</lpage>
</element-citation></ref>

<ref id="b2-kjm-99-1-50">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Valdezate</surname><given-names>S</given-names></name>
<name><surname>Garrido</surname><given-names>N</given-names></name>
<name><surname>Carrasco</surname><given-names>G</given-names></name>
<etal/>
</person-group>
<article-title>Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain</article-title>
<source>J Antimicrob Chemother</source>
<year>2017</year>
<volume>72</volume>
<fpage>754</fpage>
<lpage>761</lpage>
</element-citation></ref>

<ref id="b3-kjm-99-1-50">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Toyokawa</surname><given-names>M</given-names></name>
<name><surname>Ohana</surname><given-names>N</given-names></name>
<name><surname>Ueda</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>Identification and antimicrobial susceptibility profiles of Nocardia species clinically isolated in Japan</article-title>
<source>Sci Rep</source>
<year>2021</year>
<volume>11</volume>
<fpage>16742</fpage>
</element-citation></ref>

<ref id="b4-kjm-99-1-50">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>L&#x000f3;pez</surname><given-names>VN</given-names></name>
<name><surname>Ramos</surname><given-names>JM</given-names></name>
<name><surname>Meseguer</surname><given-names>V</given-names></name>
<etal/>
</person-group>
<article-title>Microbiology and outcome of iliopsoas abscess in 124 patients</article-title>
<source>Medicine (Baltimore)</source>
<year>2009</year>
<volume>88</volume>
<fpage>120</fpage>
<lpage>130</lpage>
</element-citation></ref>

<ref id="b5-kjm-99-1-50">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Berd</surname><given-names>D</given-names></name>
</person-group>
<article-title>Nocardia brasiliensis infection in the United States: a report of nine cases and a review of the literature</article-title>
<source>Am J Clin Pathol</source>
<year>1973</year>
<volume>60</volume>
<fpage>254</fpage>
<lpage>258</lpage>
</element-citation></ref>

<ref id="b6-kjm-99-1-50">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Noh</surname><given-names>JY</given-names></name>
<name><surname>Cheong</surname><given-names>HJ</given-names></name>
<name><surname>Heo</surname><given-names>JY</given-names></name>
<etal/>
</person-group>
<article-title>Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature</article-title>
<source>Rheumatol Int</source>
<year>2011</year>
<volume>31</volume>
<fpage>929</fpage>
<lpage>936</lpage>
</element-citation></ref>

<ref id="b7-kjm-99-1-50">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ukai</surname><given-names>Y</given-names></name>
<name><surname>Fujimoto</surname><given-names>N</given-names></name>
<name><surname>Fujii</surname><given-names>N</given-names></name>
<etal/>
</person-group>
<article-title>Case of muscle abscess due to disseminated nocardiosis in a patient with autoimmune hemolytic anemia, and review of the published work</article-title>
<source>J Dermatol</source>
<year>2012</year>
<volume>39</volume>
<fpage>466</fpage>
<lpage>469</lpage>
</element-citation></ref>

<ref id="b8-kjm-99-1-50">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kandasamy</surname><given-names>VV</given-names></name>
<name><surname>Nagabandi</surname><given-names>A</given-names></name>
<name><surname>Horowitz</surname><given-names>EA</given-names></name>
<name><surname>Vivekanandan</surname><given-names>R</given-names></name>
</person-group>
<article-title>Multidrug-resistant Nocardia pseudobrasiliensis presenting as multiple muscle abscesses</article-title>
<source>BMJ Case Rep</source>
<year>2015</year>
<volume>2015</volume>
<fpage>bcr2014205262</fpage>
</element-citation></ref>

<ref id="b9-kjm-99-1-50">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>E</given-names></name>
<name><surname>Jenney</surname><given-names>AW</given-names></name>
<name><surname>Spelman</surname><given-names>DW</given-names></name>
</person-group>
<article-title>Nocardia bacteremia: a single-center retrospective review and a systematic review of the literature</article-title>
<source>Int J Infect Dis</source>
<year>2020</year>
<volume>92</volume>
<fpage>197</fpage>
<lpage>207</lpage>
</element-citation></ref>

<ref id="b10-kjm-99-1-50">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Restrepo</surname><given-names>A</given-names></name>
<collab>Clark NM; Infectious Diseases Community of Practice of the American Society of Transplantation</collab></person-group>
<article-title>Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation</article-title>
<source>Clin Transplant</source>
<year>2019</year>
<volume>33</volume>
<elocation-id>e13509</elocation-id>
</element-citation></ref>
</ref-list>
<sec sec-type="display-objects" xml:lang="en">
		<title>Figures and Table</title>

<fig id="f1-kjm-99-1-50" position="float">
		<label>Figure 1.</label><caption><p>Radiological and intraoperative findings of the multifocal intramuscular abscess. (A) Abdominopelvic computed tomography reveals multiple peripheral enhancing fluid collections involving the left psoas and iliacus muscles. (B) Abdominopelvic computed tomography reveals multiple peripheral enhancing fluid collections involving the left gluteus maximus and piriformis. (C, D) A skin incision was made from 5 cm distal to the posterior superior iliac spine to 5 cm distal to the greater trochanter, and huge amounts of brownish pus gushed from the gluteus maximus.</p></caption>
		<graphic xlink:href="kjm-99-1-50f1.tif"/></fig>

<fig id="f2-kjm-99-1-50" position="float">
		<label>Figure 2.</label><caption><p>The fingerprint of <italic>Nocardia abscessus</italic> on MALDI-TOF MS. The sample spectrum is presented at the top and the matched database spectrum below it. The best match was with <italic>Nocardia abscessus</italic>. m/z, mass to charge ratio; MALDI-TOF MS, matrix-assisted laser desorption/ionization-time of flight mass spectrometry.</p></caption>
		<graphic xlink:href="kjm-99-1-50f2.tif"/></fig>

<table-wrap id="t1-kjm-99-1-50" position="float">
<label>Table 1.</label>
<caption><p>Clinical characteristics of muscle abscesses due to <italic>Nocardia</italic> infection: a review of literature</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Case No.</th>
<th align="center" valign="middle">Age, years/sex</th>
<th align="center" valign="middle">Predisposing condition (occupation)</th>
<th align="center" valign="middle">Immuno-suppressant</th>
<th align="center" valign="middle">Parts of muscle with abscess</th>
<th align="center" valign="middle">Other organs</th>
<th align="center" valign="middle">Species (ID period<sup><xref rid="tfn2-kjm-99-1-50" ref-type="table-fn">b</xref></sup>)</th>
<th align="center" valign="middle">Treatment regimen</th>
<th align="center" valign="middle">Dose and duration</th>
<th align="center" valign="middle">Out-come</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">39/M</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">Both psoas</td>
<td valign="top" align="left">Brain, spleen, lung</td>
<td valign="top" align="left"><italic>N. brasiliensis</italic> (after death)</td>
<td valign="top" align="left">Sulfonamide</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">Died</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">44/M</td>
<td valign="top" align="left">KT, valvular heart disease</td>
<td valign="top" align="left">Cyclosporine, prednisolone</td>
<td valign="top" align="left">Right psoas,<sup><xref rid="tfn1-kjm-99-1-50" ref-type="table-fn">a</xref></sup> gluteus maximus</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left">NA (17 days)</td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">61/M</td>
<td valign="top" align="left">CLL (gardener)</td>
<td valign="top" align="left">Cyclo-phosphamide, vincristine</td>
<td valign="top" align="left">Right psoas</td>
<td valign="top" align="left">Lung</td>
<td valign="top" align="left"><italic>N. asteroides</italic></td>
<td valign="top" align="left">Minocycline</td>
<td valign="top" align="left">100 mg ql2h, 4 months</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="center">61/M</td>
<td valign="top" align="left">KT</td>
<td valign="top" align="left">Cyclosporine, azathioprine, prednisolone</td>
<td valign="top" align="left">Right biceps brachii</td>
<td valign="top" align="left">Lung</td>
<td valign="top" align="left"><italic>N. asteroides</italic></td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">NA, 12 months</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="center">5&amp;M</td>
<td valign="top" align="left">HT (gardener)</td>
<td valign="top" align="left">Cyclosporine, azathioprine</td>
<td valign="top" align="left">Left adductor</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left"><italic>N. asteroides</italic></td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">960 mg ql2h, 1 year</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="center">42/M</td>
<td valign="top" align="left">- (cattle inspector)</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left">Left psoas</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left"><italic>N. farcinica</italic> (17 days)</td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">10 mg/kg q24h and 50 mg/kg q24h, 11 months</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">7</td>
<td valign="top" align="center" rowspan="2">40/M</td>
<td valign="top" align="left" rowspan="2">Wound dehiscence after 3rdKT</td>
<td valign="top" align="left" rowspan="2">Prednisolone, mycophenolate mofetil, tacrolimus</td>
<td valign="top" align="left" rowspan="2">Right deltoid</td>
<td valign="top" align="left" rowspan="2">Lung</td>
<td valign="top" align="left" rowspan="2"><italic>N. asteroides</italic></td>
<td valign="top" align="left" rowspan="2">TMP/SMX</td>
<td valign="top" align="left">800 mg ql2h and 160 mg ql2h, 2 weeks</td>
<td valign="top" align="left" rowspan="2">Cured</td>
</tr>
<tr>
<td valign="top" align="left">400 mgql2h and 80 mg ql2h, 1 year</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="center">32/F</td>
<td valign="top" align="left">SLE, lupus nephritis</td>
<td valign="top" align="left">Cyclo-phosphamide, prednisolone</td>
<td valign="top" align="left">Left deltoid</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left"><italic>N. farcinica</italic> (12 days)</td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="center">65/F</td>
<td valign="top" align="left">Hodgkin&#x02019;s lymphoma</td>
<td valign="top" align="left">Methotrexate, vinblastine, bleomycin</td>
<td valign="top" align="left">Right vastus lateralis</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left"><italic>N. farcinica</italic></td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">160 mg ql2h and 800 mg ql2h, 3 months</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="center">76/M</td>
<td valign="top" align="left">Suspicion of Rheumatic disorder</td>
<td valign="top" align="left">Corticosteroid</td>
<td valign="top" align="left">Left gracilis</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left"><italic>N. farcinica</italic></td>
<td valign="top" align="left">TMP/SMX</td>
<td valign="top" align="left">1,920 mgql2h, 3 months</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">11</td>
<td valign="top" align="center">46M</td>
<td valign="top" align="left">Obesity, alcoholism</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left">Ilio-psoas</td>
<td valign="top" align="left">Maxilla,<sup><xref rid="tfn1-kjm-99-1-50" ref-type="table-fn">a</xref></sup> spinal disk</td>
<td valign="top" align="left"><italic>N. asteroides</italic> (7 days)</td>
<td valign="top" align="left">Imipemen, amikacin, rifampin</td>
<td valign="top" align="left">NA, 4 months</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left">12</td>
<td valign="top" align="center">32/M</td>
<td valign="top" align="left">AIDS, hepatitis C, alcoholism</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left">Left paravertebral, psoas, maximus gluteus<sup><xref rid="tfn1-kjm-99-1-50" ref-type="table-fn">a</xref></sup></td>
<td valign="top" align="left">Lung</td>
<td valign="top" align="left"><italic>N. asteroides</italic></td>
<td valign="top" align="left">TMP/SMX, ciprofloxacin</td>
<td valign="top" align="left">NA</td>
<td valign="top" align="left">Cured</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">13</td>
<td valign="top" align="center" rowspan="3">61/F</td>
<td valign="top" align="left" rowspan="3">SLE, lupus nephritis</td>
<td valign="top" align="left" rowspan="3">Prednisolone</td>
<td valign="top" align="left" rowspan="3">Left psoas</td>
<td valign="top" align="left" rowspan="3">Lung</td>
<td valign="top" align="left" rowspan="3"><italic>N. farcinica</italic></td>
<td valign="top" align="left" rowspan="3">TMP/SMX ceftriaxone, ciprofloxacin</td>
<td valign="top" align="left">160-800 mg q8h, 9 days (azotemia)</td>
<td valign="top" align="left" rowspan="3">Cured</td>
</tr>
<tr>
<td valign="top" align="left">2 g q24h, 4 weeks</td>
</tr>
<tr>
<td valign="top" align="left">200 mg ql2h, 12 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">14</td>
<td valign="top" align="center" rowspan="3">59/F</td>
<td valign="top" align="left" rowspan="3">Autoimmune hemolytic anemia</td>
<td valign="top" align="left" rowspan="3">Prednisolone</td>
<td valign="top" align="left" rowspan="3">Left biceps femoris<sup><xref rid="tfn1-kjm-99-1-50" ref-type="table-fn">a</xref></sup></td>
<td valign="top" align="left" rowspan="3">Lung, brain</td>
<td valign="top" align="left" rowspan="3"><italic>N. farcinica</italic> (9 days)</td>
<td valign="top" align="left" rowspan="3">TMP/SMX, imipemen, amikacin</td>
<td valign="top" align="left">4,000-9,000 mg q24h, 9 months</td>
<td valign="top" align="left" rowspan="3">Cured</td>
</tr>
<tr>
<td valign="top" align="left">2,000 mg q24h, 5 months</td>
</tr>
<tr>
<td valign="top" align="left">800 mg q24h, 5 months</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">15</td>
<td valign="top" align="center" rowspan="2">79/M</td>
<td valign="top" align="left" rowspan="2">Myasthenia gravis</td>
<td valign="top" align="left" rowspan="2">Steroid</td>
<td valign="top" align="left" rowspan="2">Both biceps femoris</td>
<td valign="top" align="left" rowspan="2">Lung<sup><xref rid="tfn1-kjm-99-1-50" ref-type="table-fn">a</xref></sup></td>
<td valign="top" align="left" rowspan="2"><italic>N. pseudo-brasiliensis</italic></td>
<td valign="top" align="left" rowspan="2">Linezolid, moxifloxacin</td>
<td valign="top" align="left">NA, 3 weeks (thrombocyto-penia)</td>
<td valign="top" align="left" rowspan="2">Cured</td>
</tr>
<tr>
<td valign="top" align="left">NA, 6 months</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">This case</td>
<td valign="top" align="center" rowspan="2">73/M</td>
<td valign="top" align="left" rowspan="2">COPD, recurrent pneumo-thorax</td>
<td valign="top" align="left" rowspan="2">Prednisolone, dexamethasone</td>
<td valign="top" align="left" rowspan="2">Left psoas,<sup><xref rid="tfn1-kjm-99-1-50" ref-type="table-fn">a</xref></sup> iliacus, spinalis thoracis, longissimus thoracis, gluteus maximus, piriformis</td>
<td valign="top" align="left" rowspan="2">-</td>
<td valign="top" align="left" rowspan="2"><italic>N. abscessus</italic> (2 days)</td>
<td valign="top" align="left" rowspan="2">Levofloxacin, vancomycin</td>
<td valign="top" align="left">750 mg q24h, 7 days</td>
<td valign="top" align="left" rowspan="2">Died</td>
</tr>
<tr>
<td valign="top" align="left">900-1,000 mg ql2h, 7 days</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>ID, identification; M, male; NA, not available; <italic>N. brasiliensis, Nocardia brasiliemsis</italic>; KT, kidney transplantation; TMP/SMX, trimethoprim/sulfamethoxazole; CLL, chronic lymphocytic leukemia; <italic>N. asteroides, Nocardia asteroids</italic>; HT, heart transplantation; <italic>N. farcinica, Nocardia farcinica</italic>; F, female; SLE, systemic lupus erythematosus; AIDS, acquired immune deficiency syndrome; COPD, chronic obstructive pulmonary disease; <italic>N. pseudo-brasiliensis, Nocardia pseudo-brasilieusis; N. abscessus, Nocardia abscessus</italic>.</p></fn>
<fn id="tfn1-kjm-99-1-50"><label>a</label><p>Primary organ of infection suspected by the authors of the literature.</p></fn>
<fn id="tfn2-kjm-99-1-50"><label>b</label><p>Period until identifying <italic>Nocardia</italic> after hospitalization.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>